Format

Send to

Choose Destination
BMC Genomics. 2019 May 14;20(1):366. doi: 10.1186/s12864-019-5761-7.

Guidance for DNA methylation studies: statistical insights from the Illumina EPIC array.

Author information

1
University of Exeter Medical School, University of Exeter, RD&E Hospital, Barrack Road, Exeter, Devon, EX2 5DW, UK.
2
School of Biological Sciences, University of Essex, Colchester, Essex, CO4 3SQ, UK.
3
Institute for Social and Economic Research, University of Essex, Colchester, Essex, CO3 3LG, UK.
4
University of Exeter Medical School, University of Exeter, RD&E Hospital, Barrack Road, Exeter, Devon, EX2 5DW, UK. e.j.hannon@exeter.ac.uk.

Abstract

BACKGROUND:

There has been a steady increase in the number of studies aiming to identify DNA methylation differences associated with complex phenotypes. Many of the challenges of epigenetic epidemiology regarding study design and interpretation have been discussed in detail, however there are analytical concerns that are outstanding and require further exploration. In this study we seek to address three analytical issues. First, we quantify the multiple testing burden and propose a standard statistical significance threshold for identifying DNA methylation sites that are associated with an outcome. Second, we establish whether linear regression, the chosen statistical tool for the majority of studies, is appropriate and whether it is biased by the underlying distribution of DNA methylation data. Finally, we assess the sample size required for adequately powered DNA methylation association studies.

RESULTS:

We quantified DNA methylation in the Understanding Society cohort (n = 1175), a large population based study, using the Illumina EPIC array to assess the statistical properties of DNA methylation association analyses. By simulating null DNA methylation studies, we generated the distribution of p-values expected by chance and calculated the 5% family-wise error for EPIC array studies to be 9 × 10- 8. Next, we tested whether the assumptions of linear regression are violated by DNA methylation data and found that the majority of sites do not satisfy the assumption of normal residuals. Nevertheless, we found no evidence that this bias influences analyses by increasing the likelihood of affected sites to be false positives. Finally, we performed power calculations for EPIC based DNA methylation studies, demonstrating that existing studies with data on ~ 1000 samples are adequately powered to detect small differences at the majority of sites.

CONCLUSION:

We propose that a significance threshold of P < 9 × 10- 8 adequately controls the false positive rate for EPIC array DNA methylation studies. Moreover, our results indicate that linear regression is a valid statistical methodology for DNA methylation studies, despite the fact that the data do not always satisfy the assumptions of this test. These findings have implications for epidemiological-based studies of DNA methylation and provide a framework for the interpretation of findings from current and future studies.

KEYWORDS:

DNA methylation; Epigenome-wide association study (EWAS); Illumina EPIC array; Multiple testing; Power

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center